Rituxan: a legacy of experience

Rituxan milestones from 2002 to today

Efficacy data

Find ACR response and radiographic data in patients from the REFLEX Trial who had an inadequate response to at least 1 TNFi

Safety data

See REFLEX Trial safety data, including long-term safety data

Patient access

Get information and resources for patient financial support

ACR, American College of Rheumatology; RA, rheumatoid arthritis; TNFi, tumor necrosis factor inhibitor.